Daiichi Sankyo says it was cheated in Ranbaxy Labs Purchase, fined $500 million by the US Government
When Daiichi Sankyo purchased a controlling stake of 63.9 percent in Ranbaxy Labs as it exports drugs to almost 125 countries while owning multiple facilities in different locations, little did it know that it was in for a rude surprise. In a recent press release, the Japanese pharmaceutical company claims that previous shareholders of Ranbaxy…